A woman with progressive bilateral Mooren's ulcer developed recurrent corneal perforations and melting requiring tectonic grafts, despite conventional immunosuppressant therapy. Following treatment with infliximab, an anti-tumour necrosis factor agent, the patient showed marked reduction in conjunctival inflammation and no further recurrence of corneal thinning and perforation during 2-year follow up on maintaining treatment.
FONTANA L, Gabriella Parente, Piergiorgio Neri, Massimo Reta, Giorgio Tassinari (2007). Favourable response to infliximab in a case of bilateral Mooren's ulcer. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 35, 871-873.
Favourable response to infliximab in a case of bilateral Mooren's ulcer
FONTANA L
;
2007
Abstract
A woman with progressive bilateral Mooren's ulcer developed recurrent corneal perforations and melting requiring tectonic grafts, despite conventional immunosuppressant therapy. Following treatment with infliximab, an anti-tumour necrosis factor agent, the patient showed marked reduction in conjunctival inflammation and no further recurrence of corneal thinning and perforation during 2-year follow up on maintaining treatment.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
